Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta gr ...

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are ...

AM CET Danone to acquire Huel, extending its portfolio in Functional Nutrition Danone today announces it has entered into a ...

Powered by proprietary RVGF Technology, Introducing a New Era of Formulas, Efficacy, and Design NEW YORK, March 20, 2026 ...

EEST. Solar Foods proceeds to the next design phase of Factory 02. Solar Foods is proceeding with the design of its first ind ...

Global Well Intervention Market size, valued at USD 15.1 Billion in 2025, is projected to expand at a CAGR of 5.6% to reach ...

In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...

When jam-packed calendars and seemingly constant takeout orders get you down, diving into a fresh way to rethink homecooked ...

The Campus Dining Index is one of the largest annual surveys examining the latest dietary, food and beverage, and dining program preferences nationwide. High-protein meals rank as the top dining ...

After a Consumer Reports investigation revealed that some popular protein powders and shakes contained troubling levels of lead, many readers wrote in with a simple question: What does this mean for ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...